You are here: Industry Insights > Pharmacovigilance

News List

AI in Pharmacovigilance: Predicting & Preventing Drug Risks Nurah Ekhlaque
November 19, 2024
Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Pharmacovigilance (PV) Lin Zhang
November 04, 2020
Artificial Intelligence (AI) is a fast emerging technology, dealing with the development and study of intelligent machines and software.
The FDA Goes Live with LifeSphere MultiVigilance, Modernizing Pharmacovigilance Capabilities with FAERS II AmericanPharmaceuticalReview
December 16, 2021
ArisGlobal, a provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere®, announced the go-live of the FDA Adverse Event Reporting System (FAERS II), an electronic safety...
Pharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, Dec 2021 EuropeanPharmaceuticalReview
December 08, 2021
EMA’s drug safety committee (PRAC) confirmed the risks of of myocarditis and pericarditis with COVID-19 messenger RNA (mRNA) vaccines.
Pharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, August 2021 europeanpharmaceuticalreview
August 10, 2021
The EMA’s drug safety committee (PRAC) recommends updating risks of Janssen COVID-19 Vaccine, though the benefit-risk balance remains unchanged.
Role of pharmacovigilance in innovating and revolutionising healthcare accessibility in India expresspharma
July 29, 2021
Dr Pramod Dhembare, Founder and Managing Partner, Fidelity Health Service, traces the role of pharmacovigilance in public healthcare.
Pharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, July 2021 europeanpharmaceuticalreview
July 14, 2021
The Pharmacovigilance Risk Assessment Committee (PRAC) provided safety warnings on COVID-19 vaccines, and found no evidence linking Zynteglo to blood cancer.
Pharmacovigilance Risk Assessment Committee meeting highlights, June 2021 europeanpharmaceuticalreview
June 17, 2021
The European Medicines Agency (EMA)’s drug safety committee (PRAC) concluded three safety signal reviews, two for COVID-19 interventions, at its June meeting.
Highlights of the May 2021 Pharmacovigilance Risk Assessment Committee (PRAC) meeting europeanpharmaceuticalreview
May 11, 2021
In its May meeting, the EMA’s drug safety committee (PRAC) concluded two safety signal reviews for COVID-19 vaccines and began several more.
Global pharmacovigilance market to value almost $15bn by 2028 europeanpharmaceuticalreview
April 29, 2021
Research suggests outsourcing and the increasing incidence of adverse drug reactions (ADR) will be primary drivers of growth in the global pharmacovigilance market.